Advanced Biomed is trading 10.6% up now at $8.87, primarily on biotech-sector strength.

  • It rebounded from the August 24, 2026 close of $8.02 but remains below the August 14, 2026 close of $8.95.
  • Biotech ETF XBI rose 2.06% during regular trading amid broader risk-on sentiment.
  • No company-specific announcement, earnings release, regulatory action, or analyst catalyst has been identified for August 25, 2026; latest listed company news predates today by more than two months.